Overview

Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

Status:
Completed
Trial end date:
2019-11-25
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to evaluate the effect of AMG 510 on the pharmacokinetics (PK) of metformin in healthy participants and to evaluate the effect of metformin on the PK of AMG 510 in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen
Treatments:
Metformin